FindTrial
Sign In

Research on the relationship between AQP3 protein expression in pathological sections of patients with hepatocellular carcinoma and malignancy of hepatocellular carcinoma

Research on the relationship between AQP3 protein expression in pathological sections of patients with hepatocellular carcinoma and malignancy of hepatocellular carcinoma - The relationship between AQP3 protein expression and hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055903
Enrollment
Unknown
Registered
2022-01-23
Start date
2022-01-14
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

HCC patients:None

Sponsors

School of Basic Medicine, Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients with pathological diagnosis of HCC; 2. Patients with suspected HCC but pathological diagnosis not HCC; 3. Consent to participate in clinical research.

Exclusion criteria

Exclusion criteria: 1. Patients without HCC; 2. Do not agree to participate in clinical research.

Design outcomes

Primary

MeasureTime frame
aquaporin3;Ki67;—

Countries

China

Contacts

Public ContactLuo Huanhuan

Guangzhou University of Chinese Medicine

avenluo@gzucm.edu.cn+86 13826008227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026